A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2
Na Li(Chengdu University of Traditional Chinese Medicine), Xiaoyu Hu, Liyuan Hao(Chengdu University of Traditional Chinese Medicine), Junli Zhang(Bengbu Medical College), Shenghao Li(Hebei Medical University), Jiali Deng(Chinese Academy of Sciences), Fanghang Ye(Chengdu University of Traditional Chinese Medicine), Fei Yu(Chengdu University of Traditional Chinese Medicine)
Cited by 8
Related Papers
Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson’s disease via inhibiting oxidative stress and ferroptosis
|BMC Complementary Medicine and Therapies|2023|73
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
|Journal of Inflammation Research|2024|61
The current status and future of PD-L1 in liver cancer
|Frontiers in Immunology|2023|55
Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70
|Phytomedicine|2018|52
Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1
|Molecular and Cellular Biochemistry|2020|51